Judges Hear 1st Challenge to Medicare Drug Price Program to Hit Federal Appeals Court

The challenge to the program seems to be a part of a larger legal strategy to create a circuit split, thus increasing chances of U.S. Supreme Court review, said Andrew Twinamatsiko, director of the Health Policy and the Law Initiative at the O’Neill Institute.

       
News
Author: News

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *